Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
AssigneeStatens Serum Institut
InventorsJesper Davidsen, Peter Andersen, Ida Rosenkrands
Life of this patent
Estimating the term…
Abstract
The present invention relates to liposome formulations that are physically stable. In particular the present invention relates to steric stabilization of cationic liposomes by incorporating glycolipids into the liposomes. The stabilized liposomes can be used either as an adjuvant for antigenic components or as a drug delivery system. In particular the invention relates to vaccines with adjuvants in aqueous media for immunization, where the final product is stable.
Claims20
A method of stabilizing cationic liposomes in aqueous formulations comprising incorporating 2.5 mole % to about 95 mole % glycolipids into said cationic liposomes.
A method of stabilizing cationic liposomes in aqueous formulations comprising incorporating 2.5 mole % to about 20 mole % glycolipids selected from the group consisting of alpha,alpha′-trehalose 6,6′ dibehenate (TDB), alpha,alpha′-trehalose 6,6′ dimycolate (TDM), a ceramide and a ganglioside into the cationic liposomes prepared from dimethyldioactadecylammonium (DDA) chloride.
Dependencies are inferred from the claim text.